Our services bridge the knowledge gap in the always-advancing field of cancer research.
Explore our offerings
If you're an HR or benefits professional seeking cancer resources for your employees, or a consultant looking to provide best-in-class cancer support for your clients, share a few details below. We’ll reach out to help your company get started.
If you’re an employee looking for your AccessHope benefit, call 800.423.3232 and select Option 1.
We're changing the way leading-edge cancer expertise is delivered
Our services bridge the knowledge gap in the always-advancing field of cancer research.
Explore our offerings
Employees stay close to family as we mobilize advanced cancer knowledge.
Discover our difference
We offer employers the chance to invest in their most important investment—their people.
How AccessHope can help
City of Hope is a world renowned cancer research and treatment center based in southern California. It is a National Cancer Institute-designated comprehensive cancer center, in addition to being a founding member of the National Comprehensive Cancer Network, making it a national leader in advancing research and treatment protocols. For over a decade, City of Hope has been identified as one of the nation’s elite cancer hospitals by U.S. News & World Report.
Dana-Farber Cancer Institute in Boston, MA is a Harvard Medical School teaching hospital. It is the #1 ranked cancer hospital in New England by US News & World Report. Nationwide, it is the only cancer hospital to be ranked in the top 5 for both adult and pediatric oncology care. Dana-Farber is dedicated to a unique balance of cancer care and research, translating discovery into new therapies for patients around the world and offering more than 1,100 clinical trials.
Dana-Farber is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), an NCI-designated Comprehensive Cancer Center, a founding member of the National Comprehensive Cancer Network, the top academic recipient of grant funding from the National Cancer Institute (NCI), and has the most highly cited research of any U.S. cancer center.
Emory Healthcare, with more than 24,000 employees and 11 hospitals, is the most comprehensive academic health system in Georgia. System-wide, it has 2,796 licensed patient beds, more than 2,800 physicians practicing in more than 70 specialties, serving metro Atlanta with 250 locations. It also provides services to greater Georgia through a joint venture at St. Francis–Emory Healthcare Hospital in Columbus, 10 regional affiliate hospitals, and its clinically integrated physician network.
As the National Cancer Institute (NCI)-designated comprehensive cancer center for the state of Georgia, Winship Cancer Institute of Emory University discovers, develops and delivers some of the world's most effective ways to prevent, detect, diagnose and treat each patient's unique cancer. Winship leverages the depth and breadth of Emory University and collaborates with other NCI-designated cancer centers and leading cancer organizations. Winship investigators conducted more than 300 therapeutic clinical trials and enrolled more than 900 patients in 2020. Winship has more than 500 faculty and received $80 million in cancer research funding in 2020, $33 million of that from the NCI.
Northwestern Medicine is a nationally recognized health system that provides world-class care. Anchored by Northwestern Memorial Hospital, ranked No. 1 in Illinois and No. 9 in the nation by US News and World Report. Northwestern Medicine encompasses more than 200 locations including 10 hospitals, the Northwestern University Feinberg School of Medicine and The Robert H. Lurie Comprehensive Cancer Center.
Backed by the Lurie Cancer Center, Northwestern Memorial Hospital is ranked #9 in the nation by US News and World Report and is part of a select group of National Cancer Institute (NCI) designated Comprehensive Cancer Centers. Dedicated to overcoming cancer through scientific discovery, the Lurie Cancer Center provides compassionate, leading edge cancer care in a state of the art facility.
Fred Hutchinson Cancer Center combines adult cancer care and advanced scientific research, and has a history of discoveries that treat, cure and identify prevention strategies for cancer and infectious diseases. The organization was renamed in April 2022, following the merger of long-time partners, Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance. Fred Hutchinson Cancer Center is an independent, nonprofit organization that serves as UW Medicine’s cancer program.
Fred Hutch has been a National Cancer Institute-designated cancer center since 1973. Global leadership in bone marrow transplantation, HIV/AIDS, immunotherapy and COVID-19 helped Fred Hutch earn recognition as one of the world’s leading cancer, infectious disease and biomedical research centers. Based in Seattle, Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and has network affiliations with hospitals in five states.
As part of the Johns Hopkins Medicine academic health system and Johns Hopkins University School of Medicine, the Kimmel Cancer Center has five locations in the Baltimore and Greater Washington, D.C., regions. Designated by the National Cancer Institute as one of the first comprehensive cancer centers in the country, its physicians and scientists are recognized leaders throughout the nation and the world.
The Kimmel Cancer Center understands that each patient is unique and it provides a tailored approach to care by multidisciplinary teams of specialists. Its patients have access to a large number of clinical trials and supportive care resources for themselves and their caregivers. From immunotherapy and proton therapy, to molecular tumor board-guided treatments, its physicians, nurses, and pharmacists are dedicated to providing the best care possible backed by innovative research.
Ben Laroya, MSN, RN, PHN, CNS, explains how employees can connect with qualified personnel, including experienced oncology nurses, to discuss tips on preparing for doctor appointments, treatment information, or emotional concerns—wherever they are in their cancer journey.
AccessHope and UT Southwestern Medical Center announce a collaboration to extend access to cancer expertise in the Southern United States and beyond.
Read moreAccessHope's core mission is to improve clinical outcomes, not ROI. We recently helped a member with lung cancer avoid ineffective therapy and prevent chronic health issues from toxicities, saving our client over 372K in unnecessary expenditures.
Learn MoreA new study, published by the Journal of Personalized Medicine, highlights AccessHope’s clinical impact on 94 cases of pancreatic adenocarcinoma.
Read more“We’ve made great strides in this country making sure people have access to health benefits, but that’s different than having access to the right expertise for your cancer. Our program is there to support the treating doctor and meaningfully improve the care that that doctor is able to provide to their patient.”
- Dr. Harlan Levine
Chair of the Board, AccessHope
President, Health Innovation & Policy, City of Hope
Brad
Kreick
Chief Executive Officer
As CEO, Brad drives the overall executive management and direction of AccessHope. His prior roles include CEO of SolutionHealth, Executive Vice President of Apria Healthcare Inc., Executive Vice President, Business Development, for Oxford Health Plans Inc., in addition to consulting experience taking publicly traded and privately held healthcare provider and payor organizations through high-growth stages.
Debra
Morris
President
Debby leads day-to-day operations including operational excellence, resource management, financial strategy, and cross-functional collaboration in support of AccessHope’s vision and culture. She brings over 30 years of experience scaling private and public companies and leading teams through periods of high growth, change, and complexity, most recently as CFO and EVP at Apria Healthcare for nearly 10 years.
Peter
Bridges
Chief Strategy and Growth Officer
Peter oversees AccessHope’s Corporate Strategy and Commercial Growth teams. A seasoned healthcare executive, Peter was President of Curai Health, and also served as Ginger’s Chief Commercial Officer, where he played an integral role in the company’s substantial growth and its merger with Headspace Health, leading Ginger’s Sales, Client Success, Channel, Health Plan, Strategic Partner, and Consultant Relationship teams.
Yousuf
Zafar, M.D., MHS
Chief Medical Officer
Dr. Zafar leads AccessHope’s clinical infrastructure. He is a practicing oncologist, an
adjunct professor at Duke University, and a Fellow of the American Society of Clinical
Oncology who has authored over 100 publications focused on improving cancer care
delivery. Previously he was Senior Vice President of Medical Informatics at Optum and
Change Healthcare, and served as Director of Healthcare Innovation and Chief Quality and
Innovation Officer at Duke Cancer Institute.
Abhishek
Kumar
Chief Information Officer
Abhishek is responsible for the management, strategy and operations of IT infrastructure and oversees the IT Strategy and Information Security Program. His experience includes success with Johns Hopkins, City Of Hope and Johnson & Johnson.
Bridget
Davis
General Counsel
Bridget oversees legal, risk and compliance at AccessHope. She brings more than 35 years experience in legal practice. Most recently Bridget served as Deputy General Counsel at City of Hope, where she was instrumental in navigating complex legal challenges and fostering an environment of innovation and compliance.
Joseph
Alvarnas, M.D.
Chief Clinical Advisor | AccessHope; VP, Government Affairs and Senior Medical Director for Employer Strategy, Clinical Professor, Hematology/HCT | City of Hope
Dr. Alvarnas is AccessHope’s Chief Clinical Advisor with a passion for changing the healthcare system to ensure the delivery of first-class cancer care. He’s also a Clinical Professor of Hematology, the Vice President of Government Affairs, and the Senior Medical Director for Employer Strategy at City of Hope, a world-renowned independent cancer research and treatment center. For the center, he leads advocacy efforts at the federal, state, and local levels, and assists in developing, marketing, and operationalizing the clinical infrastructure and activities related to employer and payer strategies.
Melissa
Gilkerson
Vice President, Marketing & Communications
Melissa drives the AccessHope brand and marketing strategy and oversees member engagement. Her 20 years of experience include successive leadership roles with StayWell as well as positions with Willis Towers Watson and RBC Capital Markets.
Cory
Morin
Vice President, Foundational Partners
Cory is the VP of Foundational Partners for AccessHope. He brings 17 years of project/program management and leadership experience in the healthcare industry to his role.
AccessHope Expands Executive Leadership Team Amid Rapid Growth and Upcoming Market Expansion